# Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting

> **NCT04896164** · PHASE3 · UNKNOWN · sponsor: **Tata Memorial Centre** · enrollment: 190 (estimated)

## Conditions studied

- Oral Mucositis (Ulcerative)

## Interventions

- **DRUG:** Curcumin Lozenges
- **OTHER:** Placebo Lozenges

## Key facts

- **NCT ID:** NCT04896164
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-16
- **Primary completion:** 2025-05-16
- **Final completion:** 2025-05-16
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04896164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04896164, "Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04896164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*